Skip to content

Case series:Sequential CART cell immunotherapy

2 trials

Sponsors

Beijing Boren Hospital, Beijing Boren Hospita

Conditions

Relapsed B acute lymphoblastic leukemia after allo-HCTprimary refractory or chemotherapeutic relapsed B-cell acute lymphoblastic leukemia